AI-generated summary
The authors studied whether low-intensity laser therapy improves endothelial function in patients with chronic viral hepatitis, comparing medication alone with medication plus intravenous or cutaneous laser therapy. They report that medication alone did not significantly improve plasma NOx levels, while adding laser therapy did, which they interpret as improved nitric oxide-producing endothelial function.
- Who or what was studied
- Patients with chronic viral hepatitis divided into three groups: 30 receiving medication only, 45 receiving medication plus intravenous laser therapy, and 45 receiving medication plus cutaneous laser therapy.
- Limits stated in the abstract
- The abstract does not report the laser wavelengths, dosing, or outcome measures beyond plasma NOx, and the group allocation and statistical methods are not described.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.